Irhythm Holdings, Inc. (IRTC) Stock Price & Analysis
Irhythm Holdings, Inc. (IRTC) rose 6.15% to USD 113.83 as of June 10, 2026 at 02:24 UTC, according to Nexqual real-time market data.
IRTC last closed at USD 107.23; the session ranged USD 107.8–114.2 on volume of 569,677 shares. Market capitalization is $3.74B, with a 52-week range of USD 101.75–212 (NMS). Source: Nexqual, June 10, 2026 at 02:24 UTC.
Key Statistics (as of June 10, 2026 at 02:24 UTC)
| Price | USD 113.83 |
|---|---|
| Change | ▲ 6.15% (up) |
| Previous Close | USD 107.23 |
| Open | USD 108.06 |
| Day Range | USD 107.8 – 114.2 |
| 52-Week Range | USD 101.75 – 212 |
| Volume | 569,677 shares |
| Market Cap | $3.74B |
| Exchange | NMS |
Technical Analysis (IRTC)
Nexqual's technical model rates IRTC "NEUTRAL" based on 2 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 02:24 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.14 (neutral) |
| vs SMA50 | Below (USD 117.41) |
| MACD | -2.84 (negative) |
Analyst Ratings (IRTC)
Wall Street analysts rate IRTC "Strong Buy" based on 14 analysts, with a mean price target of USD 178.93 (range USD 147–255), per Nexqual as of June 10, 2026 at 02:24 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 14 |
| Mean Target | USD 178.93 |
| High Target | USD 255 |
| Low Target | USD 147 |
| Buy / Hold / Sell | 14 / 1 / 0 |
Earnings (IRTC)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 0 |
| Revenue Estimate | $219.28M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.35 vs est -0.64 ▲ beat |
| 2025-12-31 | USD 0.29 vs est 0.06 ▲ beat |
| 2025-09-30 | USD -0.06 vs est -0.28 ▲ beat |
| 2025-06-30 | USD -0.32 vs est -0.47 ▲ beat |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
Financials & Fundamentals (IRTC)
| Total Revenue | $787.85M |
|---|---|
| Revenue Growth (YoY) | +25.70% |
| Gross Margin | +71.00% |
| Operating Margin | -5.95% |
| Profit Margin | -3.53% |
| ROE | -22.42% |
| Debt / Equity | 452.39 |
| Current Ratio | 5.17 |
| Total Cash | $549.62M |
| Total Debt | $729.29M |
| Free Cash Flow | $57.02M |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
Financial Health Score (IRTC)
Nexqual rates Irhythm Holdings, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:24 UTC.
| Growth | Strong — Revenue +26% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 71%, operating -6% |
| Balance Sheet | Weak — $550M cash vs $729M debt |
| Cash Flow | Solid — FCF $57M, 8% margin |
| Efficiency | Critical — ROE -22%, ROA -1.1% |
Ownership (IRTC)
| Insider Ownership | +1.16% |
|---|---|
| Institutional Ownership | +111.05% |
| Shares Outstanding | 32.86M |
| Float | 30.79M |
| Short % of Float | +9.69% |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
Leadership (IRTC)
Irhythm Holdings, Inc. is led by Quentin S. Blackford (age 46), President, CEO & Director, per Nexqual as of June 10, 2026 at 02:24 UTC.
| President, CEO & Director | Quentin S. Blackford (age 46) |
|---|---|
| CFO & Principal Financial Officer | Daniel G. Wilson (age 43) |
| Executive Vice President of Business Operations | Mervin Smith (age 50) |
| Executive VP & CTO | Brian Lawrence (age 55) |
| Senior Vice President of Finance & Investor Relations | Lisa Pecora |
Major Backers & Investors (IRTC)
Notable institutional backers of Irhythm Holdings, Inc. include RTW Investments LP, Millennium Management, Artisan Partners Limited Partnership, according to Nexqual as of June 10, 2026 at 02:24 UTC.
Active Investors
| Investor | Stake |
|---|---|
| RTW Investments LP | 5.08% |
| Millennium Management | 4.89% |
| Artisan Partners Limited Partnership | 4.42% |
| FMR, LLC | 4.14% |
| Holocene Advisors, LP | 3.8% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3.19% |
| SmallCap World Fund Inc | 1.41% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 18.78% |
| BlackRock | 10.62% |
| Geode Capital | 2.49% |
Source: Nexqual, June 10, 2026 at 02:24 UTC.
From Irhythm Holdings, Inc.'s Latest SEC 10-K Filing (filed 2026-02-19)
Key Strengths & Strategy (as disclosed to the SEC)
- iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.
- The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
- It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data.
- In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PEN | Penumbra, Inc. | USD 321.06 | ▲ 0.17% |
| GKOS | Glaukos Corporation | USD 126.34 | ▲ 1.07% |
| PODD | Insulet Corporation | USD 159.61 | ▲ 4.17% |
| LIVN | LivaNova PLC | USD 77.17 | ▲ 6.65% |
| NTRA | Natera, Inc. | USD 222.82 | ▲ 3.49% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:24 UTC. This page is informational and not investment advice.